CRO Vial Highlights Clinical Trial Platform
Recent investments bring clinical trial technology platform to the fore.
Vial, a CRO that was founded in 2020, is growing awareness around its company with a recent influx of funding. Vial was formed with the goal of bringing professionals with clinical trial depth and expertise together with Silicon Valley experts to build a technology platform. This platform features three key areas of clinical trial conduct--site startup, eSource and patient recruitment—each in its own part of the platform.
For more information, please read the full release.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
